PharmaCyte Biotech, Inc. Gross Profit

• This data is from PharmaCyte Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on July 29, 2016.
• XBRL data for this metric is available from 2011 to 2016 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q4 2010: $13.0 thousand | Q1 2011: $10.0 thousand | Q3 2011: $4.1 thousand | Q4 2011: $13.8 thousand | Q1 2012: $18.1 thousand | Q3 2012: $6.6 thousand | Q4 2012: -$3.3 thousand | Q1 2013: $0.00 | Q3 2013: $0.00 | Q4 2013: $0.00 | Q1 2014: $0.00 | Q2 2014: $0.00 | Q3 2014: $0.00 | Q4 2014: $0.00 | Q1 2015: $0.00 | Q2 2015: $0.00 | Q3 2015: $0.00 | Q4 2015: $0.00 | Q1 2016: $0.00 | Q2 2016: $0.00 | Q4 2016: $0.00.
• Over the full 6 years of available data (2011 to 2016), PharmaCyte Biotech, Inc.'s Gross Profit has declined by 100.0%.
• Historical annual values: Fiscal year 2016: $0.00 | Fiscal year 2015: $0.00 | Fiscal year 2014: $0.00 | Fiscal year 2013: $2.5 thousand | Fiscal year 2012: $47.2 thousand | Fiscal year 2011: $93.9 thousand.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026